NewsPublic Affairs / February 12, 2018

Greenfield Waits For Eli Lilly And Co.'s Decision On Animal Health Business

Buildings along W. Main Street (U.S. 40) in downtown Greenfield, Indiana. - Nyttend/public domain

Buildings along W. Main Street (U.S. 40) in downtown Greenfield, Indiana.

Nyttend/public domain

GREENFIELD, Ind. (AP) — Officials in Greenfield are awaiting a company's decision on whether it will sell or spin off its animal health business, a move that could deliver a blow to the local economy.

The Indianapolis Business Journal reports that if Eli Lilly and Co. officials were to sell or spin off Elanco Animal Health, there's no guarantee the operation would remain in Greenfield. The company has had a presence in the city since it built research laboratories in the late 19th century.

Elanco employs about 775 at its campus in Greenfield, a 21,000-person city about 15 miles east of Indianapolis.

Mayor Chuck Fewell says the city would hate to lose the business.

Lilly CEO David Ricks said last month that the company would likely announce a decision by July.

At WFYI, our goal is to cover stories that matter to you. Our reporting is rooted in facts. It considers all perspectives and is available to everyone. We don't have paywalls, but we do need support. So if unbiased, trusted journalism is important to you, please join us. Donate now.

 

 

Related News

Meet The 5th Congressional District Candidates: Christina Hale, Victoria Spartz And Ken Tucker
Indianapolis Activist Works To Preserve Black Communities
BMV Extends Hours For Election Day